BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38698462)

  • 21. Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis.
    Ding P; Xu Y; Li L; Lv X; Li L; Chen J; Zhou D; Wang X; Wang Q; Zhang W; Liao T; Ji QH; Lei QY; Hu W
    Cell Rep; 2022 May; 39(9):110851. PubMed ID: 35649359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting ferroptosis as a vulnerability in cancer.
    Lei G; Zhuang L; Gan B
    Nat Rev Cancer; 2022 Jul; 22(7):381-396. PubMed ID: 35338310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
    Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
    J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.
    Zhang X; Qu YY; Liu L; Qiao YN; Geng HR; Lin Y; Xu W; Cao J; Zhao JY
    Cell Rep; 2021 Oct; 37(2):109821. PubMed ID: 34644569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.
    Scagliola A; Miluzio A; Ventura G; Oliveto S; Cordiglieri C; Manfrini N; Cirino D; Ricciardi S; Valenti L; Baselli G; D'Ambrosio R; Maggioni M; Brina D; Bresciani A; Biffo S
    Nat Commun; 2021 Aug; 12(1):4878. PubMed ID: 34385447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
    Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
    Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis, radiotherapy, and combination therapeutic strategies.
    Lei G; Mao C; Yan Y; Zhuang L; Gan B
    Protein Cell; 2021 Nov; 12(11):836-857. PubMed ID: 33891303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FCN3 functions as a tumor suppressor of lung adenocarcinoma through induction of endoplasmic reticulum stress.
    Jang H; Jun Y; Kim S; Kim E; Jung Y; Park BJ; Lee J; Kim J; Lee S; Kim J
    Cell Death Dis; 2021 Apr; 12(4):407. PubMed ID: 33859174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadening horizons: the role of ferroptosis in cancer.
    Chen X; Kang R; Kroemer G; Tang D
    Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer.
    Lee JY; Nam M; Son HY; Hyun K; Jang SY; Kim JW; Kim MW; Jung Y; Jang E; Yoon SJ; Kim J; Kim J; Seo J; Min JK; Oh KJ; Han BS; Kim WK; Bae KH; Song J; Kim J; Huh YM; Hwang GS; Lee EW; Lee SC
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32433-32442. PubMed ID: 33288688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer.
    Wohlhieter CA; Richards AL; Uddin F; Hulton CH; Quintanal-Villalonga À; Martin A; de Stanchina E; Bhanot U; Asher M; Shah NS; Hayatt O; Buonocore DJ; Rekhtman N; Shen R; Arbour KC; Donoghue M; Poirier JT; Sen T; Rudin CM
    Cell Rep; 2020 Dec; 33(9):108444. PubMed ID: 33264619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
    Yi J; Zhu J; Wu J; Thompson CB; Jiang X
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis.
    Hong X; Roh W; Sullivan RJ; Wong KHK; Wittner BS; Guo H; Dubash TD; Sade-Feldman M; Wesley B; Horwitz E; Boland GM; Marvin DL; Bonesteel T; Lu C; Aguet F; Burr R; Freeman SS; Parida L; Calhoun K; Jewett MK; Nieman LT; Hacohen N; Näär AM; Ting DT; Toner M; Stott SL; Getz G; Maheswaran S; Haber DA
    Cancer Discov; 2021 Mar; 11(3):678-695. PubMed ID: 33203734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion.
    Zou Y; Henry WS; Ricq EL; Graham ET; Phadnis VV; Maretich P; Paradkar S; Boehnke N; Deik AA; Reinhardt F; Eaton JK; Ferguson B; Wang W; Fairman J; Keys HR; Dančík V; Clish CB; Clemons PA; Hammond PT; Boyer LA; Weinberg RA; Schreiber SL
    Nature; 2020 Sep; 585(7826):603-608. PubMed ID: 32939090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
    Nassar ZD; Mah CY; Dehairs J; Burvenich IJ; Irani S; Centenera MM; Helm M; Shrestha RK; Moldovan M; Don AS; Holst J; Scott AM; Horvath LG; Lynn DJ; Selth LA; Hoy AJ; Swinnen JV; Butler LM
    Elife; 2020 Jul; 9():. PubMed ID: 32686647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interaction between ferroptosis and lipid metabolism in cancer.
    Li D; Li Y
    Signal Transduct Target Ther; 2020 Jun; 5(1):108. PubMed ID: 32606298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression.
    Wu Y; Zhang S; Gong X; Tam S; Xiao D; Liu S; Tao Y
    Mol Cancer; 2020 Feb; 19(1):39. PubMed ID: 32103754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis: past, present and future.
    Li J; Cao F; Yin HL; Huang ZJ; Lin ZT; Mao N; Sun B; Wang G
    Cell Death Dis; 2020 Feb; 11(2):88. PubMed ID: 32015325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death.
    Tesfay L; Paul BT; Konstorum A; Deng Z; Cox AO; Lee J; Furdui CM; Hegde P; Torti FM; Torti SV
    Cancer Res; 2019 Oct; 79(20):5355-5366. PubMed ID: 31270077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.